Allicor

DIETARY_SUPPLEMENT3 trials

Sponsors

Institute for Atherosclerosis Research, Russia

Conditions

AtherosclerosisCarotid AtherosclerosisCoronary ArteriosclerosisCoronary Artery Bypass GraftingMyocardial IschemiaPercutaneous Coronary RevascularizationPeripheral Arterial Disease

Phase 3

Atherosclerosis Monitoring and Atherogenicity Reduction Study

CompletedNCT01734707

Institute for Atherosclerosis Research, RussiaCarotid Atherosclerosis

Start: 2004-01-31End: 2005-10-31Updated: 2012-11-28

Phase 4

The Effects of Allicor on Patients After Coronary Arteria Revascularization Treatment

Institute for Atherosclerosis Research, RussiaCoronary Arteriosclerosis, Coronary Artery Bypass Grafting, Myocardial Ischemia +1

Start: 2023-04-10End: 2025-03-31Target: 200Updated: 2023-04-19

The Effects of Allicor on Patients After Revascularization Treatment During a Year

Institute for Atherosclerosis Research, RussiaAtherosclerosis, Peripheral Arterial Disease

Start: 2023-04-20End: 2024-05-31Target: 300Updated: 2023-04-19